2021 annual financial data
Aptevo Therapeutics 2021 Operating margin
Direct answer
Operating margin was -174.1%.
Operating income was -21,400,000 USD and net income was -27,313,000 USD.
Operating cash flow was -21,679,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,292,000 USD
- Operating income
- -21,400,000 USD
- Net income
- -27,313,000 USD
- Operating cash flow
- -21,679,000 USD